These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36344781)

  • 21. Gut Microbiome of Children and Adolescents With Primary Sclerosing Cholangitis in Association With Ulcerative Colitis.
    Cortez RV; Moreira LN; Padilha M; Bibas MD; Toma RK; Porta G; Taddei CR
    Front Immunol; 2020; 11():598152. PubMed ID: 33613519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-TNF Therapy Response in Patients with Ulcerative Colitis Is Associated with Colonic Antimicrobial Peptide Expression and Microbiota Composition.
    Magnusson MK; Strid H; Sapnara M; Lasson A; Bajor A; Ung KA; Öhman L
    J Crohns Colitis; 2016 Aug; 10(8):943-52. PubMed ID: 26896085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Moxibustion treatment modulates the gut microbiota and immune function in a dextran sulphate sodium-induced colitis rat model.
    Qi Q; Liu YN; Jin XM; Zhang LS; Wang C; Bao CH; Liu HR; Wu HG; Wang XM
    World J Gastroenterol; 2018 Jul; 24(28):3130-3144. PubMed ID: 30065559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inulin-type fructans improve active ulcerative colitis associated with microbiota changes and increased short-chain fatty acids levels.
    Valcheva R; Koleva P; Martínez I; Walter J; Gänzle MG; Dieleman LA
    Gut Microbes; 2019; 10(3):334-357. PubMed ID: 30395776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mucosa-associated gut microbiota reflects clinical course of ulcerative colitis.
    Nishihara Y; Ogino H; Tanaka M; Ihara E; Fukaura K; Nishioka K; Chinen T; Tanaka Y; Nakayama J; Kang D; Ogawa Y
    Sci Rep; 2021 Jul; 11(1):13743. PubMed ID: 34215773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in intestinal microbiota and correlation with TLRs in ulcerative colitis in the coastal area of northern China.
    Xu N; Bai X; Cao X; Yue W; Jiang W; Yu Z
    Microb Pathog; 2021 Jan; 150():104707. PubMed ID: 33352216
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis.
    Mintz M; Khair S; Grewal S; LaComb JF; Park J; Channer B; Rajapakse R; Bucobo JC; Buscaglia JM; Monzur F; Chawla A; Yang J; Robertson CE; Frank DN; Li E
    PLoS One; 2018; 13(1):e0190997. PubMed ID: 29385143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low counts of Faecalibacterium prausnitzii in colitis microbiota.
    Sokol H; Seksik P; Furet JP; Firmesse O; Nion-Larmurier I; Beaugerie L; Cosnes J; Corthier G; Marteau P; Doré J
    Inflamm Bowel Dis; 2009 Aug; 15(8):1183-9. PubMed ID: 19235886
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Partners of patients with ulcerative colitis exhibit a biologically relevant dysbiosis in fecal microbial metacommunities.
    Chen GL; Zhang Y; Wang WY; Ji XL; Meng F; Xu PS; Yang NM; Ye FQ; Bo XC
    World J Gastroenterol; 2017 Jul; 23(25):4624-4631. PubMed ID: 28740351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth-promoting effect of alginate on Faecalibacterium prausnitzii through cross-feeding with Bacteroides.
    Murakami R; Hashikura N; Yoshida K; Xiao JZ; Odamaki T
    Food Res Int; 2021 Jun; 144():110326. PubMed ID: 34053530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls.
    Kummen M; Holm K; Anmarkrud JA; Nygård S; Vesterhus M; Høivik ML; Trøseid M; Marschall HU; Schrumpf E; Moum B; Røsjø H; Aukrust P; Karlsen TH; Hov JR
    Gut; 2017 Apr; 66(4):611-619. PubMed ID: 26887816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alterations in the gut microbiome of children with severe ulcerative colitis.
    Michail S; Durbin M; Turner D; Griffiths AM; Mack DR; Hyams J; Leleiko N; Kenche H; Stolfi A; Wine E
    Inflamm Bowel Dis; 2012 Oct; 18(10):1799-808. PubMed ID: 22170749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Temporal Gut Microbial Changes Predict Recurrent Clostridiodes Difficile Infection in Patients With and Without Ulcerative Colitis.
    Lee AA; Rao K; Limsrivilai J; Gillilland M; Malamet B; Briggs E; Young VB; Higgins PDR
    Inflamm Bowel Dis; 2020 Oct; 26(11):1748-1758. PubMed ID: 31971239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Colonisation by Faecalibacterium prausnitzii and maintenance of clinical remission in patients with ulcerative colitis.
    Varela E; Manichanh C; Gallart M; Torrejón A; Borruel N; Casellas F; Guarner F; Antolin M
    Aliment Pharmacol Ther; 2013 Jul; 38(2):151-61. PubMed ID: 23725320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Matching Strategy To Guide Donor Selection for Ulcerative Colitis in Fecal Microbiota Transplantation: Meta-Analysis and Analytic Hierarchy Process.
    Zhang B; Yang L; Ning H; Cao M; Chen Z; Chen Q; Lian G; Tang H; Wang Q; Wang J; Lin Z; Wen J; Liu Y; Xuan J; Li X; Lin A; He J; Zhang L; Hou X; Zeng Q; Xiao C
    Microbiol Spectr; 2023 Feb; 11(1):e0215921. PubMed ID: 36472435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between clinical features and intestinal microbiota in Chinese patients with ulcerative colitis.
    He XX; Li YH; Yan PG; Meng XC; Chen CY; Li KM; Li JN
    World J Gastroenterol; 2021 Jul; 27(28):4722-4737. PubMed ID: 34366632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ulcerative Colitis in Response to Fecal Microbiota Transplantation via Modulation of Gut Microbiota and Th17/Treg Cell Balance.
    Huang C; Mei Q; Lou L; Huang Z; Fu Y; Fan J; Wang J; Yin N; Zheng Y; Lu Y; Zeng Y
    Cells; 2022 Jun; 11(11):. PubMed ID: 35681546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis.
    Machiels K; Joossens M; Sabino J; De Preter V; Arijs I; Eeckhaut V; Ballet V; Claes K; Van Immerseel F; Verbeke K; Ferrante M; Verhaegen J; Rutgeerts P; Vermeire S
    Gut; 2014 Aug; 63(8):1275-83. PubMed ID: 24021287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 2,3,5,4'-Tetrahydroxystilbene-2-O-β-D-glucoside, a major bioactive component from Polygoni multiflori Radix (Heshouwu) suppresses DSS induced acute colitis in BALb/c mice by modulating gut microbiota.
    He X; Liu J; Long G; Xia XH; Liu M
    Biomed Pharmacother; 2021 May; 137():111420. PubMed ID: 33761623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in the Abundance of Faecalibacterium prausnitzii Phylogroups I and II in the Intestinal Mucosa of Inflammatory Bowel Disease and Patients with Colorectal Cancer.
    Lopez-Siles M; Martinez-Medina M; Surís-Valls R; Aldeguer X; Sabat-Mir M; Duncan SH; Flint HJ; Garcia-Gil LJ
    Inflamm Bowel Dis; 2016 Jan; 22(1):28-41. PubMed ID: 26595550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.